SCHEMBL14749421

SCHEMBL14749421

CS(=O)(=O)N1CC(c2cc(-c3ccc(Cl)cc3)nn2-c2ncccn2)CCC1c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRCP P42785 8/20 0.55
▸ PSEN1 P49768 1/20 0.39
▸ PSEN2 P49810 1/20 0.39
▸ APH1B Q8WW43 1/20 0.39
▸ NCSTN Q92542 1/20 0.39
▸ APH1A Q96BI3 1/20 0.39
▸ PSENEN Q9NZ42 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ PSD A5PKW4 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ IKBKB O14920 1/20 0.35
▸ PTPN1 P18031 1/20 0.34
▸ PGR P06401 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14737070 0.85 PRCP (0.54) PRCPSMN1; SMN2MAPTPOLBMEN1
SCHEMBL12184147 0.84 PRCP (0.60) PRCPSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL2599450 0.83 PRCP (0.55) PRCPSMN1; SMN2MAPTPOLBMEN1
SCHEMBL12184095 0.83 PRCP (0.55) PRCPSMN1; SMN2MAPTPOLBMEN1
SCHEMBL12184748 0.83 PRCP (0.50) PRCPALDH1A1SMN1; SMN2MAPTPOLB
SCHEMBL14749302 0.81 PRCP (0.48) PRCPSMN1; SMN2MAPTPOLB
SCHEMBL14752639 0.81 PRCP (0.52) PRCPALDH1A1SMN1; SMN2MAPTPOLB
SCHEMBL14736813 0.76 PRCP (0.56) PRCPSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL14737395 0.76 PRCP (0.56) PRCPSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL12184580 0.75 PRCP (0.56) PRCPSMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130059830-A1 NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS MERCK SHARP & DOHME CORP 2013-03-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059830-A1 NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS PRCP, PREP, ENPEP PRCP 1/4885PSEN1 916/4885PSEN2 1918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback